...
首页> 外文期刊>Journal of Pharmaceutical and Biomedical Analysis: An International Journal on All Drug-Related Topics in Pharmaceutical, Biomedical and Clinical Analysis >An integrative urinary metabolomic study of the therapeutic effect of Guizhi Fuling capsule on primary dysmenorrheal rats based H-1 NMR and UPLC-MS
【24h】

An integrative urinary metabolomic study of the therapeutic effect of Guizhi Fuling capsule on primary dysmenorrheal rats based H-1 NMR and UPLC-MS

机译:桂花茯苓胶囊治疗基于H-1 NMR和UPLC-MS对初级吞咽大鼠的治疗作用的一体化尿代谢研究

获取原文
获取原文并翻译 | 示例
           

摘要

Guizhi Fuling capsule (GFC) was an important traditional Chinese herbal medicine used for the treatment of primary dysmenorrheal (PD). The aim of this study was to evaluate the anti-dysmenorrheal effect of GFC on dysmenorrheal rats induced by oxytocin and to investigate its mechanism of action. An integrative urinary metabolomic study based on H-1 NMR and UPLC-MS was used to investigate the therapeutic effect of GFC on PD rats. In addition, in order to obtain more potential biomarkers and to investigate the global urine metabolic profile associated with PD, we combined the characteristics of RP-UPLC-MS with HILIC-UPLC-MS on metabolomic platform to find non-polar and polar metabolites. Finally, a total of 36 potential biomarkers were identified as being primarily involved in the TCA cycle, gluconeogenesis, glycolysis, pentose phosphate pathway, lipid metabolism, energy metabolism, amino acid metabolism and intestinal flora metabolism, and PD could influence the balance of many of these metabolic pathways in vivo. Furthermore, these results also suggested that the GFC had therapeutic effects on PD rats via the regulation of multiple metabolic pathways. In conclusion, the variations in potential biomarkers revealed the therapeutic mechanism of GFC, and these potential biomarkers were both significant for early diagnosis and predicting PD. (C) 2018 Elsevier B.V. All rights reserved.
机译:桂芝茯苓胶囊(GFC)是一种重要的中草药,用于治疗原发性吞噬(PD)。本研究的目的是评估GFC对催产素诱导的痛经大鼠的抗痛经效应,并研究其作用机制。基于H-1 NMR和UPLC-MS的一体化尿代谢物研究探讨GFC对PD大鼠的治疗效果。另外,为了获得更多潜在的生物标志物并研究与PD相关的全球尿代谢谱,我们将RP-UPLC-MS与HILIC-UPLC-MS的特性将RP-UPLC-MS对代谢组平台的特征组合以找到非极性和极性代谢物。最后,共鉴定了36种潜在的生物标志物,主要涉及TCA循环,葡甘油生成,糖酵解,戊糖磷酸盐途径,脂质代谢,能量代谢,氨基酸代谢和肠道菌群代谢,并且PD可能影响许多人的平衡这些代谢途径在体内。此外,这些结果还表明GFC通过对多种代谢途径的调节对PD大鼠进行了治疗作用。总之,潜在的生物标志物的变化揭示了GFC的治疗机制,这些潜在的生物标志物对早期诊断和预测PD都显着。 (c)2018年elestvier b.v.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号